Production and utilization of unconventional radiometals for advanced diagnostics and therapy

Medicine and Dentistry

• Radioisotope 100%
• Diagnosis 100%
• Dosimetry 40%
• Target Tissue 40%
• Internalization 40%
• Tetraxetan 40%
• Lutetium 177 40%
• Zirconium 89 40%
• Metalloprotein 40%
• Copper 64 20%
• Targeted Radionuclide Therapy 20%
• Infection 20%
• Therapy Effect 20%
• Biodistribution 20%
• Fluorine-18 20%
• Chelating Agent 20%
• Radiopharmaceutical Agent 20%
• Carbon 11 20%
• Cell Nucleus 20%
• Cancer 20%
• Nuclear Medicine 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Radioisotope 100%
• Dosimetry 33%
• Metalloprotein 33%
• Tetraxetan 33%
• Lutetium 177 33%
• Zirconium 89 33%
• Therapeutic Effect 16%
• Infection 16%
• Chelating Agent 16%
• Biodistribution 16%
• Carbon 11 16%
• Copper 64 16%
• Fluorine 18 16%
• Radiopharmaceutical Agent 16%

Keyphrases

• 165Er 40%
• Long Circulation Time 20%
• Intact Antibody 20%
• Serum Stability 20%